U.S. administers 218.9 million doses of COVID-19 vaccines - CDC
- Inflation angst bruises world stocks
- Bitcoin Falls as Musk Says Tesla (TSLA) Will Suspend Vehicle Purchases Using Bitcoin, Citing Use of Fossil Fuels in Mining
- Dollar holds gains after inflation surprise; Bitcoin partly recovers
- Silvergate Capital (SI) to be the Exclusive Issuer of U.S. Dollar Backed Stablecoins by Diem (FB)
- Cathie Wood's ARK Adds Another 2.1M Shares of Palantir (PLTR) on Wednesday
FILE PHOTO: Nurse Nicole McCurrach, 48, draws up coronavirus disease (COVID-19) vaccinations at Richmond raceway in Richmond, Virginia, U.S., March 4, 2021. REUTERS/Julia Rendleman
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
(Reuters) - The United States has administered 218,947,643 doses of COVID-19 vaccines in the country and distributed 282,183,915 doses as of Thursday morning, the U.S. Centers for Disease Control and Prevention said.
Those figures are up from the 215,951,909 vaccine doses the CDC said had been given to people by April 21 out of 277,938,875 doses delivered.
The agency said 135,791,031 people had received at least one dose, while 89,245,776 people were fully vaccinated as of Thursday.
The CDC tally includes two-dose vaccines from Moderna and Pfizer/BioNTech, as well as Johnson & Johnson's one-shot vaccine.
A total of 7,783,990 vaccine doses have been administered in long-term care facilities, the agency said.
(Reporting by Mrinalika Roy in Bengaluru; Editing by Shinjini Ganguli)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Prudential shares fall as Jackson demerger shifts to second half
- Red-hot and rural: Canadian towns grapple with big-city-like real estate boom
- India's cenbank tells lenders to re-consider ties with crypto exchanges, traders
Create E-mail Alert Related CategoriesReuters
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!